CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Stock Information for Curative Biotechnology Inc Com

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Curative Biotechnology Inc Com

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
CorMedix Announces Strategic Minority Investment in Talphera
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
CorMedix to Participate in Upcoming Investor Conferences
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
Grabar Law Office Investigates Claims on Behalf of Shareholders of CorMedix Inc. (CRMD) as Securities Fraud Class Action Survives Motion to Dismiss
Grabar Law Office Investigates Claims on Behalf of Shareholders of CorMedix Inc. (CRMD) as Securities Fraud Class Action Survives Motion to Dismiss

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.